Concepts (61)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Human Embryonic Stem Cells | 2 | 2022 | 32 | 1.540 |
Why?
|
| Ventricular Fibrillation | 2 | 2015 | 57 | 0.940 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2022 | 223 | 0.710 |
Why?
|
| Myocytes, Cardiac | 6 | 2023 | 696 | 0.640 |
Why?
|
| Anti-Arrhythmia Agents | 3 | 2021 | 235 | 0.600 |
Why?
|
| Heart Diseases | 1 | 2023 | 722 | 0.570 |
Why?
|
| Myocardial Infarction | 2 | 2023 | 1154 | 0.570 |
Why?
|
| Hypokalemia | 1 | 2015 | 61 | 0.500 |
Why?
|
| Tachycardia, Ventricular | 2 | 2016 | 199 | 0.490 |
Why?
|
| Action Potentials | 6 | 2022 | 588 | 0.450 |
Why?
|
| Triazoles | 2 | 2015 | 629 | 0.420 |
Why?
|
| Cardiovascular Diseases | 1 | 2023 | 2213 | 0.350 |
Why?
|
| Heart Failure | 1 | 2023 | 2330 | 0.350 |
Why?
|
| Pyridines | 2 | 2015 | 1310 | 0.350 |
Why?
|
| Rats, Inbred F344 | 2 | 2015 | 235 | 0.240 |
Why?
|
| Pericytes | 1 | 2023 | 90 | 0.210 |
Why?
|
| Rats | 5 | 2021 | 6396 | 0.200 |
Why?
|
| Heart Ventricles | 3 | 2022 | 837 | 0.200 |
Why?
|
| RNA Splicing | 1 | 2023 | 362 | 0.190 |
Why?
|
| Mexiletine | 1 | 2021 | 5 | 0.190 |
Why?
|
| Cardiac Conduction System Disease | 1 | 2021 | 16 | 0.190 |
Why?
|
| Cell Differentiation | 2 | 2022 | 4105 | 0.180 |
Why?
|
| Long QT Syndrome | 1 | 2021 | 111 | 0.170 |
Why?
|
| Heart | 2 | 2023 | 1173 | 0.160 |
Why?
|
| Rabbits | 2 | 2021 | 1040 | 0.160 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2021 | 501 | 0.150 |
Why?
|
| Myocardium | 2 | 2023 | 1180 | 0.140 |
Why?
|
| Stem Cell Transplantation | 1 | 2023 | 1420 | 0.130 |
Why?
|
| Phenethylamines | 1 | 2015 | 13 | 0.130 |
Why?
|
| Benzylamines | 1 | 2015 | 98 | 0.130 |
Why?
|
| Calcium | 1 | 2021 | 1569 | 0.130 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2015 | 131 | 0.120 |
Why?
|
| Aconitine | 1 | 2013 | 11 | 0.120 |
Why?
|
| Fibrosis | 3 | 2023 | 715 | 0.100 |
Why?
|
| Computer Simulation | 1 | 2015 | 1567 | 0.090 |
Why?
|
| Animals | 7 | 2023 | 61340 | 0.080 |
Why?
|
| Molecular Targeted Therapy | 1 | 2019 | 2396 | 0.080 |
Why?
|
| Hypertension | 1 | 2016 | 1584 | 0.070 |
Why?
|
| Sulfonamides | 1 | 2015 | 1942 | 0.060 |
Why?
|
| Humans | 6 | 2023 | 270637 | 0.060 |
Why?
|
| RNA Splicing Factors | 1 | 2023 | 151 | 0.050 |
Why?
|
| Ventricular Remodeling | 1 | 2023 | 186 | 0.050 |
Why?
|
| Drug Stability | 1 | 2021 | 105 | 0.050 |
Why?
|
| NAV1.5 Voltage-Gated Sodium Channel | 1 | 2021 | 43 | 0.050 |
Why?
|
| Half-Life | 1 | 2021 | 268 | 0.050 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 7317 | 0.040 |
Why?
|
| Cells, Cultured | 2 | 2021 | 5657 | 0.040 |
Why?
|
| Extracellular Matrix | 1 | 2023 | 523 | 0.040 |
Why?
|
| Alternative Splicing | 1 | 2023 | 610 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2021 | 974 | 0.040 |
Why?
|
| Drug Design | 1 | 2021 | 371 | 0.040 |
Why?
|
| Male | 4 | 2021 | 128446 | 0.040 |
Why?
|
| Renin-Angiotensin System | 1 | 2019 | 103 | 0.040 |
Why?
|
| Biocompatible Materials | 1 | 2019 | 202 | 0.040 |
Why?
|
| Behavior, Animal | 1 | 2021 | 750 | 0.040 |
Why?
|
| Adult | 1 | 2023 | 82023 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 1 | 2021 | 2419 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2021 | 2139 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2016 | 598 | 0.030 |
Why?
|
| Mice | 2 | 2023 | 35414 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2019 | 12033 | 0.010 |
Why?
|